
Sawarn Pharma Private Limited
Founded in 2024 and headquartered in Uttar Pradesh, India.
Founded in 2024 and headquartered in Uttar Pradesh, India.
Sawarn Pharma Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 March 2024 ( 11 months 17 days old ). Its registered office is in Gautam Buddha Nagar, Uttar Pradesh, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kumar Pappu and Priya Kumari serve as directors at the Company.
Gautam Buddha Nagar, Uttar Pradesh, India
+91-XXXXXXXXXX
U46497UP2024PTC200197
200197
Private Limited Indian Non-Government Company
30 Mar 2024
-
-
Unlisted
Roc Kanpur
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kumar Pappu ![]() | Director | 30-Mar-2024 | Current |
Priya Kumari ![]() | Director | 30-Mar-2024 | Current |
Enhance accessibility to Sawarn Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Sawarn Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sawarn Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sawarn Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sawarn Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Kumar Pappu was appointed as a Director was appointed as a Director on 30 Mar 2024 & has been associated with this company since 11 months 17 days .
Priya Kumari was appointed as a Director was appointed as a Director on 30 Mar 2024 & has been associated with this company since 11 months 17 days .
Sawarn Pharma Private Limited was registered on 30 Mar 2024 with Roc Kanpur & aged 11 months 17 days as per MCA records.
Sawarn Pharma Private Limited was incorporated on 30 Mar 2024.
The authorized share capital of Sawarn Pharma Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Sawarn Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Sawarn Pharma Private Limited is C/O Ankit Kumar Dabra Gautam Budh Nagar, Buddha India, Maicha, Uttar Pradesh, 201310.
The corporate identification number (CIN) of Sawarn Pharma Private Limited is U46497UP2024PTC200197 and the company number is 200197 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.